Home > News > Headline News > Archive

Click on title to read the full article.

Within sight: the end of breast cancer

August 21, 2010

By The Times (London)

I’m looking down a powerful microscope at breast cancer cells, a little cluster of them multiplying all by themselves in a nutritious pink culturing fluid. You can barely see them unless you’re told what to look for — they’re insignificant, irregular, too chaotic to make a person die. But they do:

Susan G. Komen for the Cure® and Ovarian Cancer National Alliance Appeal to FDA and Key Lawmakers on Avastin Issue

August 14, 2010

By Susan G. Komen Foundation

Susan G. Komen for the Cure® and the Ovarian Cancer National Alliance (OCNA) today urged the U.S. Food and Drug Administration (FDA) to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.

Protein Helps Predict Cancer Therapy-induced Heart Damage

August 11, 2010

By National Cancer Institute (NCI)

In a prospective study of 251 women with HER2-positive breast cancer, women with elevated blood levels of a protein called troponin I had significantly higher rates of cardiotoxicity (heart damage) during treatment with trastuzumab (Herceptin) than women who did not have elevated levels of troponin I before or during treatment.